3-46709583-TAAGAAGAAGAAGAAG-TAAGAAGAAGAAGAAGAAG

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_147196.3(TMIE):​c.391_393dupAAG​(p.Lys131dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.010 ( 26 hom., cov: 0)
Exomes 𝑓: 0.0024 ( 0 hom. )

Consequence

TMIE
NM_147196.3 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.773

Publications

21 publications found
Variant links:
Genes affected
TMIE (HGNC:30800): (transmembrane inner ear) This gene encodes a transmembrane inner ear protein. Studies in mouse suggest that this gene is required for normal postnatal maturation of sensory hair cells in the cochlea, including correct development of stereocilia bundles. This gene is one of multiple genes responsible for recessive non-syndromic deafness (DFNB), also known as autosomal recessive nonsyndromic hearing loss (ARNSHL), the most common form of congenitally acquired inherited hearing impairment. [provided by RefSeq, Mar 2009]
TMIE Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 6
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 3-46709583-T-TAAG is Benign according to our data. Variant chr3-46709583-T-TAAG is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 179307.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.01 (1506/150044) while in subpopulation AFR AF = 0.0293 (1195/40790). AF 95% confidence interval is 0.0279. There are 26 homozygotes in GnomAd4. There are 680 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147196.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMIE
NM_147196.3
MANE Select
c.391_393dupAAGp.Lys131dup
conservative_inframe_insertion
Exon 4 of 4NP_671729.2
TMIE
NM_001370524.1
c.232_234dupAAGp.Lys78dup
conservative_inframe_insertion
Exon 4 of 4NP_001357453.1
TMIE
NM_001370525.1
c.232_234dupAAGp.Lys78dup
conservative_inframe_insertion
Exon 5 of 5NP_001357454.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMIE
ENST00000643606.3
MANE Select
c.391_393dupAAGp.Lys131dup
conservative_inframe_insertion
Exon 4 of 4ENSP00000494576.2
TMIE
ENST00000644830.1
c.232_234dupAAGp.Lys78dup
conservative_inframe_insertion
Exon 4 of 4ENSP00000495111.1
TMIE
ENST00000651652.1
c.*313_*315dupAAG
3_prime_UTR
Exon 2 of 2ENSP00000498953.1

Frequencies

GnomAD3 genomes
AF:
0.00999
AC:
1498
AN:
149934
Hom.:
25
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0292
Gnomad AMI
AF:
0.0698
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00637
Gnomad EAS
AF:
0.000591
Gnomad SAS
AF:
0.00381
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00629
GnomAD2 exomes
AF:
0.00599
AC:
872
AN:
145554
AF XY:
0.00539
show subpopulations
Gnomad AFR exome
AF:
0.0514
Gnomad AMR exome
AF:
0.00567
Gnomad ASJ exome
AF:
0.00801
Gnomad EAS exome
AF:
0.000711
Gnomad FIN exome
AF:
0.000129
Gnomad NFE exome
AF:
0.00263
Gnomad OTH exome
AF:
0.00483
GnomAD4 exome
AF:
0.00239
AC:
3353
AN:
1402534
Hom.:
0
Cov.:
0
AF XY:
0.00224
AC XY:
1567
AN XY:
698872
show subpopulations
African (AFR)
AF:
0.0326
AC:
1037
AN:
31782
American (AMR)
AF:
0.00309
AC:
135
AN:
43630
Ashkenazi Jewish (ASJ)
AF:
0.00450
AC:
114
AN:
25346
East Asian (EAS)
AF:
0.000438
AC:
17
AN:
38818
South Asian (SAS)
AF:
0.00257
AC:
218
AN:
84782
European-Finnish (FIN)
AF:
0.000174
AC:
9
AN:
51750
Middle Eastern (MID)
AF:
0.00320
AC:
18
AN:
5628
European-Non Finnish (NFE)
AF:
0.00151
AC:
1600
AN:
1062698
Other (OTH)
AF:
0.00353
AC:
205
AN:
58100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
205
410
614
819
1024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0100
AC:
1506
AN:
150044
Hom.:
26
Cov.:
0
AF XY:
0.00930
AC XY:
680
AN XY:
73120
show subpopulations
African (AFR)
AF:
0.0293
AC:
1195
AN:
40790
American (AMR)
AF:
0.00425
AC:
64
AN:
15060
Ashkenazi Jewish (ASJ)
AF:
0.00637
AC:
22
AN:
3452
East Asian (EAS)
AF:
0.000592
AC:
3
AN:
5064
South Asian (SAS)
AF:
0.00360
AC:
17
AN:
4720
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10192
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00190
AC:
128
AN:
67484
Other (OTH)
AF:
0.00670
AC:
14
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
67
134
201
268
335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00189
Hom.:
1309

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 11, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lys131_Asp132insLys in Exon 4 of TMIE: This variant is not expected to have clin ical significance because it results in the an insertion of a Lys residue in a p oly-Lysine tract.

not provided Benign:2
Sep 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hearing loss, autosomal recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.77
Mutation Taster
=89/11
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10578999; hg19: chr3-46751073; COSMIC: COSV58405725; COSMIC: COSV58405725; API